SLC7A5 and central nervous system cancer: Kaplan–Meier survival analysis reveals that patients with high LAT1 expression have significantly shorter OS and PFS compared to those with low LAT1 expression, further indicating that LAT1 could serve as a potential prognostic marker for poor outcomes in gliomas [7,8,16].